The company have informed us that they are no longer seeking regulatory approval in this indication. Therefore the appraisal is suspended.
| Status | Discontinued |
| Technology type | Medicine |
| Decision | Selected |
| Reason for decision | Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources |
| Further information | The company have informed us that they are no longer seeking regulatory approval in this indication. Therefore the appraisal is suspended. |
| Process | TA |
| ID number | 1021 |
Email enquiries
- If you have any queries please email scheduling@nice.org.uk
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 23 August 2022 | Discontinued. The company have informed us that they are no longer seeking regulatory approval in this indication. Therefore the appraisal is suspended. |
For further information on our processes and methods, please see our CHTE processes and methods manual